Silo Pharma, Inc. (SILO)

Silo Pharma Statistics

Total Valuation

Silo Pharma has a market cap or net worth of $7.01 million. The enterprise value is -$25,169.

Market Cap	7.01M
Enterprise Value	-25,169

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

Silo Pharma has 16.27 million shares outstanding. The number of shares has increased by 127.76% in one year.

Current Share Class	16.27M
Shares Outstanding	16.27M
Shares Change (YoY)	+127.76%
Shares Change (QoQ)	+43.38%
Owned by Insiders (%)	2.67%
Owned by Institutions (%)	7.46%
Float	15.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	94.78
Forward PS	n/a
PB Ratio	0.93
P/TBV Ratio	1.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.36

Current Ratio	11.36
Quick Ratio	10.55
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-114.76

Financial Efficiency

Return on equity (ROE) is -74.56% and return on invested capital (ROIC) is -47.19%.

Return on Equity (ROE)	-74.56%
Return on Assets (ROA)	-35.63%
Return on Invested Capital (ROIC)	-47.19%
Return on Capital Employed (ROCE)	-61.55%
Weighted Average Cost of Capital (WACC)	7.48%
Revenue Per Employee	$24,034
Profits Per Employee	-$1.41M
Employee Count	3
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.35% in the last 52 weeks. The beta is 0.59, so Silo Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-59.35%
50-Day Moving Average	0.35
200-Day Moving Average	0.50
Relative Strength Index (RSI)	57.07
Average Volume (20 Days)	8,806,228

Short Selling Information

The latest short interest is 67,438, so 0.41% of the outstanding shares have been sold short.

Short Interest	67,438
Short Previous Month	134,766
Short % of Shares Out	0.41%
Short % of Float	0.43%
Short Ratio (days to cover)	0.16

Income Statement

In the last 12 months, Silo Pharma had revenue of $72,102 and -$4.23 million in losses. Loss per share was -$0.50.

Revenue	72,102
Gross Profit	27,807
Operating Income	-4.28M
Pretax Income	-4.23M
Net Income	-4.23M
EBITDA	-4.27M
EBIT	-4.28M
Loss Per Share	-$0.50

Balance Sheet

The company has $6.86 million in cash and n/a in debt, with a net cash position of $6.86 million or $0.42 per share.

Cash & Cash Equivalents	6.86M
Total Debt	n/a
Net Cash	6.86M
Net Cash Per Share	$0.42
Equity (Book Value)	6.31M
Book Value Per Share	0.47
Working Capital	6.74M

Cash Flow

Operating Cash Flow	-4.66M
Capital Expenditures	n/a
Depreciation & Amortization	11,440
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	38.57%
Operating Margin	-5,936.95%
Pretax Margin	-5,863.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Silo Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-127.76%
Shareholder Yield	-127.76%
Earnings Yield	-61.87%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date	Sep 15, 2022
Split Type	Reverse
Split Ratio	1:50

Scores

Silo Pharma has an Altman Z-Score of -1.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.71
Piotroski F-Score	1